5AM Venture Management, LLC
CIK
1799883
Location
SAN FRANCISCO, CA
Portfolio Value
Small
$282,021,658
Diversification
Diversified
Filing Date
Global Rank
#5,404
/ 8,794
▼ 1171
· as of Jun 2026
Top Industry
Biotechnology
100.0%
Period ended 3 months ago
Filed Aug 14, 2026 · 52d
26 quarters · since Mar 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
16 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
12.1%
−4.9 pts
Top 5
53.2%
−5.7 pts
Top 10
87.4%
+3.6 pts
HHI
843
Diversified−95
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $282,021,658 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SRZN | Surrozen, Inc./DE | −116,250 | 271,250 | $7,038,937 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
16 tracked positions ·
$282,021,658 total
· filing declares
16 positions · $287,891,952
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Held | 950,011 | $34,048,394 | 12.07% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 1,029,298 | $32,875,778 | 11.66% | |
| TRDA |
Entrada Therapeutics, Inc.
Healthcare
|
Held | 4,056,379 | $29,854,949 | 10.59% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 797,600 | $27,581,008 | 9.78% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
Held | 5,869,091 | $25,647,927 | 9.09% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
Held | 2,353,304 | $22,827,048 | 8.09% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Held | 606,660 | $20,856,970 | 7.40% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Held | 3,947,913 | $19,147,378 | 6.79% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 497,270 | $18,503,416 | 6.56% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Held | 1,050,000 | $15,015,000 | 5.32% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 738,972 | $10,995,903 | 3.90% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Reduced | 271,250 | $7,038,937 | 2.50% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
Held | 3,057,325 | $6,328,662 | 2.24% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
Held | 1,369,782 | $5,232,567 | 1.86% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Held | 476,200 | $5,228,676 | 1.85% | |
| SKYE |
Skye Bioscience, Inc.
Healthcare
|
Held | 9,681,763 | $839,045 | 0.30% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.